Applied Therapeutics, Inc. (APLT) Revenue History
Annual and quarterly revenue from 2017 to present
APLT Revenue Over Time (2017–2024)
APLT Revenue Growth History
0 of 1 years with positive growth- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- -95.4%
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $1.0M | +719.7% |
| Q2 2025 | $0 | -100.0% |
| Q1 2025 | $0 | -100.0% |
| Q4 2024 | $0 | +100.0% |
| Q3 2024 | $122K | — |
| Q2 2024 | $144K | — |
| Q1 2024 | $190K | -98.2% |
| Q4 2023 | $-667,000 | — |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2024)
APLT's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
APLT Revenue Analysis (2017–2024)
Current Revenue & Growth
As of June 28, 2026, Applied Therapeutics, Inc. (APLT) generated trailing twelve-month (TTM) revenue of $1.0 million, reflecting explosive growth of +719.7% year-over-year. The most recent quarter (Q3 2025) recorded $1.0 million in revenue
Historical Growth Trajectory
APLT's historical revenue data shows various trends over time. Applied Therapeutics, Inc.'s highest annual revenue of $10.0 million was recorded in 2023.
Revenue by Segment
APLT's revenue is primarily driven by Research and Development Services (100%). With over half of revenue concentrated in Research and Development Services, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including RARE (+13.3% YoY), FOLD (+20.0% YoY), and ACAD (+9.9% YoY) — APLT has outperformed the peer group in revenue growth. Compare APLT vs RARE →
APLT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| APLTCurrent | $1M | +719.7% | - | -22922.9% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 PTCT | $1.7B | -53.3% | +35.4% | 49.5% | |
 KRYS | $389M | +25.1% | - | 41.5% |
APLT Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $455K | -95.4% | $-48,289,000 | -10613.0% | $-104,299,000 | -22922.9% |
| 2023 | $10.0M | - | $-43,912,000 | -439.4% | $-64,535,000 | -645.8% |
| 2022 | $0 | - | $-441,000 | - | $-82,950,000 | - |
| 2021 | $0 | - | $0 | - | $-105,618,000 | - |
| 2020 | $0 | - | $0 | - | $-94,466,000 | - |
| 2019 | $0 | - | $-23,000 | - | $-45,582,000 | - |
| 2018 | $0 | - | $0 | - | $-13,518,000 | - |
| 2017 | $0 | - | $0 | - | $-4,285,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
APLT — Frequently Asked Questions
Quick answers to the most common questions about buying APLT stock.
Is APLT's revenue growth accelerating or slowing?
APLT revenue growth is accelerating. TTM revenue reached $1M, up +719.7% year-over-year — ahead of the 5-year CAGR of N/A. This indicates the business is expanding faster than its historical baseline.
What is APLT's revenue history from 2017 to 2026?
Applied Therapeutics, Inc. (APLT) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $1M, growing at +719.7% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is APLT's long-term revenue growth rate (CAGR)?
Applied Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +719.7% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for APLT.
Why does APLT's quarterly revenue fluctuate?
APLT quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Applied Therapeutics, Inc.'s revenue data from 2017 to 2026 shows full historical quarterly detail on this page.
How is APLT's revenue distributed by segment?
APLT reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does APLT's revenue compare to industry peers?
Applied Therapeutics, Inc. (APLT) with TTM revenue of $1M and +719.7% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.